The growing resistance of klebsiella pneumoniae; The need to expand our antibiogram: Case report and review of the literature

African Journal of Infectious Diseases

Volumn 7, Issue 1, 2013, Pages 8-10

  Garbati, Musa A ^a   Godhair, Areedj I Al ^b  

^a Section of Infectious Diseases   (Saudi Arabia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

Infection; Intensive care unit; Klebsiella pneumoniae; Pan drug resistance

Indexed keywords

AMIKACIN; COLISTIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CARDIOMEGALY; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; NONHUMAN; REVIEW;

EID: 84874372114     PISSN: 20060165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., and Bartlett, J., (2009). Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America. Clin. Infect. Dis., 48: 1-12.
2. CDC (2010). Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. MMWR., 59: 750.
3. Chopra, I., Schofield, C., Everett, M., O'Neill, A., Miller, K., Wilcox, M., Frère, J., Dawson, M., Czaplewski, L., Urleb, U., and Courvalin, P., (2008). Treatment of health-care associated infections caused by gram-negative bacteria: a consensus statement. Lancet Infect. Dis., 8: 133-139.
4. Infectious Diseases Society of America (2010). The 10 x '20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis., 50: 1081-1083.
5. Neuner, E. A., Yeh, J. Y., Hall, G. S., Sekeres, J., Endimiani, A., Bonomo, R. A., Shrestha, N. K., Fraser, T. G., and van Duin, D., (2011). Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections. Diagn. Microbiol. Infect. Dis., 69(4): 357-362.
6. Patel, G., Huprikar, S., Factor, S. H., Jenkins, S. G., and Calfee, D. P., (2008). Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect. Control Hosp. Epidemiol., 29(12): 1099-1106.
7. Paterson, D. L., Wen-Chien, K., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., Rice, L. B., Wagener, M. M., McCormack, J. G., and Yu, V. L., (2004). International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections. Ann. Intern. Med., 140: 26-32.
8. Peterson, L. R. (2009). Bad Bugs, No Drugs: No ESCAPE Revisited. CID., 49(6): 992-993.
9. Quale, J. (2008). Global Spread of Carbapenemase-Producing Klebsiella pneumoniae. Microbe., 3(11): 516-520.
10. Robledo, I. E., Aquino, E. E., Sante, M. I., Santana, J. L., Otero, D. M., León, C. F. and Vázquez GJ (2010). Detection of KPC in Acinetobacter sp. in Puerto Rico. Antimicrob. Agents Chemother., 54: 1354-1357.
11. Srinivasan, A., and Patel, J. B. (2008). Klebsiella pneumoniae carbapenemase-producing organisms: an ounce of prevention really is worth a pound of cure. Infect. Control Hosp. Epidemiol., 29: 1107-1109.
12. Talbot, G. H., Bradley, J., Edwards, J. E. Jr, Gilbert, D., Scheld, M., and Bartlett, J. G. (2006). Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. CID., 42: 657-668.
13. Urban, C., Bradford, P. A., Tuckman, M., Maurer, S., Wehbeh, W., Grenner, L., Urban, R. C., Mariano, N., and Rahal, J. J. (2008). Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase blactamases associated with long-term care facilities. Clin. Infect. Dis., 46: e127-130.
14. Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P., and the Colombian Nosocomial Resistance Study Group (2007). First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob. Agents Chemother., 51: 1553-1555.
15. Yigit, H., Queenman, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., and Tenover, F. C. (2001). Novel carbapenemhydrolyzing b-lactamase, KPC-1, from a carbapenemresistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother., 45: 1151-1161.
16. Zarkotou, O., Pournaras, S., Voulgari, E., Chrysos, G., Prekates, A., Voutsinas, D., Themeli-Digalaki, K., and Tsakris, A. (2010). Risk Factors and Outcomes Associated with Acquisition of Colistin-Resistant KPC-Producing Klebsiella pneumoniae: a Matched Case-Control Study. J. Clin. Microbiol., 48(6): 2271-2274.